Investment funds have developed an interest in trading capital for royalties on drug commercializations
Jeffrey Jung
Advertisement
Articles by Jeffrey Jung
Advertisement
Latest Updated Articles
- Monetizing Intellectual Property: Royalties, Revenues and Alternative Sources of Capital
Published: April 10th 2010 | Updated:
Advertisement
Advertisement
Trending on Pharmaceutical Commerce
1
Mark Cuban Confirms Cost Plus Drugs Partnership
2
Why Rising Complexity and R&D Costs Are Fueling Specialty Drug Spending
3
Pharma Pulse: Telehealth Medication Abortion Requests Surge, FDA Expedites Tzield Review, and New Biopharma Air Network Launches
4
The Hidden Costs of Prior Authorizations and Patient Loneliness
5
